Literature DB >> 6794405

Hormonal and metabolic effects of a pancreatic endocrine graft. Vascularized segmental transplantation in insulin-dependent diabetic patients.

D E Sutherland, J S Najarian, B Z Greenberg, B J Senske, G E Anderson, R S Francis, F C Goetz.   

Abstract

A new modification of pancreas transplant technique, the vascularized segmental intraperitoneal graft without duct ligation, has provided reversal of insulin-dependent (type I) diabetes mellitus for as long as 2 years of comfortable life. Although the risks associated with immunosuppression remain high (two of the 12 patients have died of early postoperative infection), selected data are presented from six cases to show the following striking hormonal and metabolic results after transplantation and withdrawal of insulin: restoration of normal beta cell function as shown by 24-hour urine C-peptide excretion and acutely responsive serum insulin, restoration of normal suppressibility of plasma glucagon, elimination of ketosis and negative nitrogen balance, normal fasting plasma glucose and glycosylated hemoglobin, and normal or near-normal glucose tolerance. These results provide a standard for current explorations of new ways of treating insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794405     DOI: 10.7326/0003-4819-95-5-537

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Pancreas transplantation: indications and outcomes.

Authors:  D E Sutherland
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation.

Authors:  A Secchi; S Martinenghi; R Caldara; E La Rocca; V Di Carlo; G Pozza
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

Review 3.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

4.  Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation.

Authors:  G Pozza; J Traeger; J M Dubernard; A Secchi; A E Pontiroli; E Bosi; M C Malik; A Ruitton; N Blanc
Journal:  Diabetologia       Date:  1983-04       Impact factor: 10.122

5.  Minnesota experience with 85 pancreas transplants between 1978 and 1983.

Authors:  D E Sutherland; P L Chinn; F C Goetz; B A Elick; J S Najarian
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

6.  One hundred pancreas transplants at a single institution.

Authors:  D E Sutherland; F C Goetz; J S Najarian
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

7.  Recent experience with 89 pancreas transplants at a single institution.

Authors:  D E Sutherland; F C Goetz; J S Najarian
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge.

Authors:  P Calhoun; K S Brown; D A Krusch; E Barido; A H Farris; W G Schenk; L E Rudolf; D K Andersen; J B Hanks
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

10.  Quality of life of pancreas transplant recipients.

Authors:  C L Zehrer; C R Gross
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.